UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054363
Receipt number R000062076
Scientific Title The effect of lactic acid bacteria ingestion combined with resistance training on muscle hypertrophy
Date of disclosure of the study information 2024/05/31
Last modified on 2025/04/02 16:32:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of lactic acid bacteria ingestion combined with resistance training on muscle hypertrophy

Acronym

The effect of lactic acid bacteria ingestion combined with resistance training on muscle hypertrophy

Scientific Title

The effect of lactic acid bacteria ingestion combined with resistance training on muscle hypertrophy

Scientific Title:Acronym

The effect of lactic acid bacteria ingestion combined with resistance training on muscle hypertrophy

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the effect of lactic acid bacteria ingestion during 12 weeks of resistance training on muscle hypertrophy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skeletal muscle mass

Key secondary outcomes

Body composition
Abdominal visceral fat mass
Inflammation-related biomarkers
Intestinal flora
Muscle soreness
Safety assessment


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Resistance training (2 times per week)
Ingestion of low dose lactic acid bacteria powder, twice per day, 12 weeks

Interventions/Control_2

Resistance training (2 times per week)
Ingestion of high dose lactic acid bacteria powder, twice per day, 12 weeks

Interventions/Control_3

Resistance training (2 times per week)
Ingestion of placebo powder, twice per day, 12 weeks

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

60 years-old >

Gender

Male

Key inclusion criteria

1.Subjects who can give informed consent to participate in this study
2.Males aged 30 to 59 years old
3.Subjects who perform exercises at least once a month

Key exclusion criteria

1. Subjects who have a chronic medical condition undergoing treatment, or who have a history of a serious illness
2. Subjects who have a disease that causes temporary muscle spasms or loss of consciousness
3. Subjects who have significant orthopedic injuries
4. Subjects who restricted exercise or bathing due to medical reasons
5. Subjects who are allergic to milk, wheat, orange, beef, sesame, soy, chicken, banana, apple, or gelatin
6. Subjects who use drugs that may affect the results of the study
7. BMI<18.5, BMI>=30
8. Smoker
9. Heavy drinkers
10. Subjects who perform resistance training using barbells, dumbbells or machines at least once a week
11. Subjects who participate other clinical studies
12. Subjects who are judged as unsuitable for the study by the principal investigator for other reason

Target sample size

36


Research contact person

Name of lead principal investigator

1st name Chiaki
Middle name
Last name Sanbongi

Organization

Meiji Co., Ltd.

Division name

R&D Division

Zip code

192-0919

Address

1-29-1 Nanakuni, Hachiouji, Tokyo, Japan

TEL

+81-42-632-5847

Email

chiaki.sanbongi@meiji.com


Public contact

Name of contact person

1st name Aya
Middle name
Last name Yoshimura

Organization

Meiji Co., Ltd.

Division name

R&D Division

Zip code

192-0919

Address

1-29-1 Nanakuni, Hachiouji, Tokyo, Japan

TEL

+81-42-632-5847

Homepage URL


Email

aya.yoshimura.aa@meiji.com


Sponsor or person

Institute

Meiji Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Meiji Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Ritsumeikan University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F, Daiwa Bldg.3-3-10 Nihonbashi Hongokucho, Chuo-ku, Tokyo, Japan

Tel

+81-3-6225-9005

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

MIJ24C4

Org. issuing International ID_1

CPCC Company Limited

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社 明治 研究本部
(R&D Division, Meiji Co., Ltd.)


Other administrative information

Date of disclosure of the study information

2024 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 04 Month 22 Day

Date of IRB

2024 Year 04 Month 19 Day

Anticipated trial start date

2024 Year 06 Month 09 Day

Last follow-up date

2024 Year 11 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 05 Month 10 Day

Last modified on

2025 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062076